CSI Market
Sign In | Register

Novabridge Biosciences (NBP) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access NBP Annual Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Novabridge Biosciences adapts its asset base and funding mix.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
0 0 0 (Dec 31 2024)
Assets
Cash & cash equivalent30.12
Short-term Investments, Total0.21
Cash & Short-term Investments30.00
Other Receivables0.01
Prepaid Expense And Other Assets Current0.95
Total Current Assets31.10
Equipment/Property/Plant Net0.14
Long-term investments0.00
Other Assets, Noncurrent6.03
Total Assets37.25
Liabilities
Accounts Payable and Accrued Liabilities, Current LI2.41
Accrued Liabilities, Current0.40
Other Liabilities, Current0.00
Total Current Liabilities3.85
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent0.10
Other liabilities, Noncurrent1.33
Total Liabilities4.23
Stockholders' Equity
Common Stock Value0.03
Additional Paid In Capital Common Stock218.32
Retained Earnings / Accumulated Deficit-190.52
Accumulated Other Comprehensive Income5.94
Other Equity5.94
Common Stockholder's Equity273.01
Total Stockholder's Equity33.02
Liabilities & Stockholder's Equity37.25
4 historic quarters locked

Sign in to unlock the full Novabridge Biosciences balance sheet history.

Sign In Create Free Account

About Novabridge Biosciences Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 20-F filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 20-F (Period: 20251231)
  • Filed with the SEC: April 7, 2026
  • Source: nbp-20251231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001778016-26-000002

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.